Mebendazole
مبندازول
🐛 Antiparasitic Products, Insecticides And RepellentsBenzimidazole anthelmintic
Market / country: 🇺🇸 USA
Emverm (US) · Vermox (US)
🧮 Dose calculator
Pinworm (enterobiasis) · Regimen source: FDA Emverm · 2, Table 1
- • If not cured 3 weeks after treatment, a second course is advised. May be chewed, swallowed or crushed. FDA Emverm · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to mebendazole. FDA Emverm · 4
- ⛔ Not established under 2 years; convulsions reported under 1 year. FDA Emverm · 8.4
Warnings
- • Avoid with metronidazole (serious skin reactions). FDA Emverm · 17
Formulations
- 100 mg chewable tablet — chewable tablet 🇺🇸 USA FDA Emverm · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Emverm · 8.1
“Risk Summary The available published literature on mebendazole use in pregnant women has not reported a clear association between mebendazole and a potential risk of major birth defects or miscarriages [see Data].”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Emverm · 8.2
“Risk Summary Limited data from case reports demonstrate that a small amount of mebendazole is present in human milk following oral administration.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Emverm · 8.4
“The safety and effectiveness of EMVERM ® 100 mg chewable tablets has not been established in pediatric patients less than two years of age.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Emverm · 8.5
“Clinical studies of mebendazole did not include sufficient numbers of subjects aged 65 and older to determine whether they respond differently from younger subjects.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA073580
- DailyMed (FDA label)FDA Emverm
- MedlinePlus (NIH)Mebendazole
- WHO ATC/DDDP02CA01
- Darooyab (Iran)Mebendazole
🇮🇷 Registered in Iran Darooyab · G-242/Mebendazole
Dosage forms with Iranian generic codes, per Darooyab.
- 00786 · MEBENDAZOLE 100MG CHEWABLE TAB · قرص جویدنی مبندازول ۱۰۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Emverm · 3FDA Emverm · 2, Table 1FDA Emverm · 2FDA Emverm · 4FDA Emverm · 8.4FDA Emverm · 17FDA Emverm · 8.1FDA Emverm · 8.2FDA Emverm · 8.5FDA Emverm · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-242/Mebendazole
- Clinical review⚠ Unverified